The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma | BMC Medical Genetics | Full Text

The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma | BMC Medical Genetics | Full Text

BMC Medical Genetics

Volume 20 Supplement 1

Selected articles from BGRS\SB-2018: medical genetics

• Research
• Open Access

The CIMP-high phenotype is associated with energy metabolism alterations in colon adenocarcinoma

• Maria S. Fedorova†,
• George S. Krasnov†,
• Elena N. Lukyanova,
• Andrew R. Zaretsky,
• Alexey A. Dmitriev,
• Nataliya V. Melnikova,
• Alexey A. Moskalev,
• Sergey L. Kharitonov,
• Elena A. Pudova,
• Zulfiya G. Guvatova,
• Anastasiya A. Kobelyatskaya,
• Irina A. Ishina,
• Elena N. Slavnova,
• Anastasia V. Lipatova,
• Maria A. Chernichenko,
• Dmitry V. Sidorov,
• Anatoly Y. Popov,
• Marina V. Kiseleva,
• Andrey D. Kaprin,
• Anastasiya V. Snezhkina and
• Anna V. KudryavtsevaEmail author

†Contributed equally

BMC Medical Genetics201920 (Suppl 1) :52

https://doi.org/10.1186/s12881-019-0771-5

©  The Author(s). 2019

• Published: 9 April 2019

Abstract

Background

CpG island methylator phenotype (CIMP) is found in 15–20% of malignant colorectal tumors and is characterized by strong CpG hypermethylation over the genome. The molecular mechanisms of this phenomenon are not still fully understood. The development of CIMP is followed by global gene expression alterations and metabolic changes. In particular, CIMP-low colon adenocarcinoma (COAD), predominantly corresponded to consensus molecular subtype 3 (CMS3, “Metabolic”) subgroup according to COAD molecular classification, is associated with elevated expression of genes participating in metabolic pathways.

Methods

We performed bioinformatics analysis of RNA-Seq data from The Cancer Genome Atlas (TCGA) project for CIMP-high and non-CIMP COAD samples with DESeq2, clusterProfiler, and topGO R packages. Obtained results were validated on a set of fourteen COAD samples with matched morphologically normal tissues using quantitative PCR (qPCR).

Results

Upregulation of multiple genes involved in glycolysis and related processes (ENO2, PFKP, HK3, PKM, ENO1, HK2, PGAM1, GAPDH, ALDOA, GPI, TPI1, and HK1) was revealed in CIMP-high tumors compared to non-CIMP ones. Most remarkably, the expression of the PKLR gene, encoding for pyruvate kinase participating in gluconeogenesis, was decreased approximately 20-fold. Up to 8-fold decrease in the expression of OGDHLgene involved in tricarboxylic acid (TCA) cycle was observed in CIMP-high tumors. Using qPCR, we confirmed the increase (4-fold) in the ENO2expression and decrease (2-fold) in the OGDHL mRNA level on a set of COAD samples.

Conclusions

We demonstrated the association between CIMP-high status and the energy metabolism changes at the transcriptomic level in colorectal adenocarcinoma against the background of immune pathway activation. Differential methylation of at least nine CpG sites in OGDHL promoter region as well as decreased OGDHL mRNA level can potentially serve as an additional biomarker of the CIMP-high status in COAD.

Keywords

• Colon adenocarcinoma
• CIMP
• RNA-Seq
• TCGA
• Energy metabolism